About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our research group is accredited by the Agency for Management of University and Research Grants (AGAUR) in Catalonia, and focuses on two main areas of interest which are related to Solid Organ Transplantation and especially Kidney, and in clinical Nephrology. We tackle these areas from an innovative perspective, both basic-experimental and mechanistic, always with a translational goal. On the one hand, we investigate, develop, and use novel diagnostic and therapeutic technologies to decipher and target main molecular and immune mechanisms of transplant rejection as well as the immune susceptibility to opportunistic infections and malignancies. Also, a main task force of the group is devoted to better understand the main mechanisms involved in certain autoimmune glomerular diseases and idiopathic nephrotic syndrome as well as in diabetic kidney disease, having a specific interest in the role of the renin-angiotensin system. Our ultimate goal is to improve the management and care of patients suffering from kidney diseases as well as their quality of life, reducing associated morbidity and mortality.
PMID: 35265335 Journal: Clinical Kidney Journal Year: 2022 Reference: Clin Kidney J. 2021 Jul 10;15(1):5-13. doi: 10.1093/ckj/sfab131. eCollection 2022 Jan. Impact factor: 4.452 Publication type: Review in international publication Authors: Montero, Nuria, Oliveras, Laia, Soler, Maria Jose, Cruzado, Josep Maria et al. DOI: 10.1093/ckj/sfab131
PMID: 35268550 Journal: Journal of Clinical Medicine Year: 2022 Reference: J Clin Med. 2022 Mar 7;11(5). pii: jcm11051459. doi: 10.3390/jcm11051459. Impact factor: 4.242 Publication type: Paper in international publication Authors: Mast, Richard, Vergara, Ander, Agraz, Irene, Leon, Juan Carlos, Bolufer, Monica, Gabaldon, Maria-Alejandra, Seron, Daniel, Bestard, Oriol, Soler, Maria Jose, Garcia-Carro, Clara et al. DOI: 10.3390/jcm11051459
PMID: 34851532 Journal: CLINICAL TRANSPLANTATION Year: 2022 Reference: Clin Transplant. 2022 Mar;36(3):e14550. doi: 10.1111/ctr.14550. Epub 2021 Dec 17. Impact factor: 2.863 Publication type: Paper in international publication Authors: Andres, Amado, Rivera, Constantino Fernandez, Rodriguez, Maria Calvo, Poveda, Jose Luis, Pascual, Julio, Crespo, Marta, Gomez, Gonzalo, Pelegrin, Sheila Cabello, Paul, Javier, Lauzurica, Ricardo et al. DOI: 10.1111/ctr.14550
PMID: 33150431 Journal: NEPHROLOGY DIALYSIS TRANSPLANTATION Year: 2022 Reference: Nephrol Dial Transplant. 2022 Feb 25;37(3):409-420. doi: 10.1093/ndt/gfaa219. Impact factor: 5.992 Publication type: Paper in international publication Authors: Malyszko, Jolanta, Basak, Grzegorz, Batko, Krzysztof, Capasso, Giavambatista, Drozd-Sokolowska, Joanna, Krzanowska, Katarzyna, Kulicki, Pawel, Matuszkiewicz-Rowinska, Joanna, Soler, Maria Jose Romeo, Sprangers, Ben et al. DOI: 10.1093/ndt/gfaa219
PMID: 33777371 Journal: Clinical Kidney Journal Year: 2021 Reference: Clin Kidney J. 2020 May 4;14(3):884-890. doi: 10.1093/ckj/sfaa027. eCollection 2021 Mar. Impact factor: 4.452 Publication type: Paper in international publication Authors: Draibe, Juliana B, Garcia-Carro, Clara, Martinez-Valenzuela, Laura, Agraz, Irene, Fulladosa, Xavier, Bolufer, Monica, Tango, Ariel, Torras, Joan, Soler, Maria Jose et al. DOI: 10.1093/ckj/sfaa027
PMID: 33756067 Journal: AMERICAN JOURNAL OF TRANSPLANTATION Year: 2021 Reference: Am J Transplant. 2021 Jul;21(7):2573-2582. doi: 10.1111/ajt.16579. Epub 2021 Apr 12. Impact factor: 8.086 Publication type: Paper in international publication Authors: Villanego, Florentino, Mazuecos, Auxiliadora, Perez-Flores, Isabel M, Moreso, Francesc, Andres, Amado, Jimenez-Martin, Carlos, Molina, Maria, Canal, Cristina, Sanchez-Camara, Luis A, Zarraga, Sofia et al. DOI: 10.1111/ajt.16579
PMID: 33166580 Journal: KIDNEY INTERNATIONAL Year: 2021 Reference: Kidney Int. 2021 Apr;99(4):986-998. doi: 10.1016/j.kint.2020.10.014. Epub 2020 Nov 7. Impact factor: 10.612 Publication type: Paper in international publication Authors: Espinosa, Mario, Egido, Jesus, Segarra, Alfonso, Lambeau, Gerard, Ronco, Pierre, Wetzels, Jack, Praga, Manuel, Plaisier, Emmanuelle, Shabaka, Amir, Romera, Ana et al. DOI: 10.1016/j.kint.2020.10.014
PMID: 33714629 Journal: NEFROLOGIA Year: 2021 Reference: Nefrologia (Engl Ed). 2021 Mar 10. pii: S0211-6995(21)00031-X. doi: 10.1016/j.nefro.2021.01.002. Impact factor: 2.033 Publication type: Paper in national publication Authors: Lopes, Vanessa, Ramos, Carmela, Mendez, Irene, Cao, Mercedes, Dominguez, Fernando, Ortiz, Alberto, Martin-Conde, Maria Luisa, Gutierrez, Maria Jose, Quiroga, Borja, Corchete, Elena et al. DOI: 10.1016/j.nefro.2021.01.002
The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.
Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.
The new findings were presented at the American Society of Nephrology's Kidney Week 2024 meeting in San Diego and simultaneously published in the prestigious journal Nature Medicine.
